A recent alliance between two CataloniaBio & HealthTech members, the LEITAT Technological Center and the Institute for Bioengineering of Catalonia (IBEC), will give a new impulse in the development and application of cutting-edge technologies that will combine engineering and biology to find solutions to health problems. Both institutions have established a new agreement to promote innovation in different scientific and technological areas, including 3D bioprinting with bioinks.
The concept is based on an open creative space, in which researchers from both institutions can collaborate with other institutions or companies from different sectors, for the improvement and maturation of different technologies derived from common development activities. In this environment, joint participation in international innovation initiatives and programs such as those included in the new Horizon Europe or Health Program will be promoted and favoured. This alliance will also serve as an instrument to develop joint research units for proof-of-concept projects.
One of the areas of common strategic interest is the development of bioinks for bioprinting and 3D models. The collaboration of two widely consolidated R+D+I partners will allow the development and optimization of a wide spectrum of bioinks produced in clinical grade, suitable to favour the development of new lines of research that will transform the world of transplantation and regenerative medicine, as we understand it today.
“With this collaboration, we want to obtain therapeutic solutions that significantly improve the life quality of people”, explains Esteve Trias, Medical Director of Leitat. “By combining the best bioengineering with industrial development, we can offer new tools to move towards solutions to health problems”, adds Josep Samitier, Director of IBEC.
You may also be interested in:
Comments